Guidelines for prevention and treatment of colorectal adenoma with integrated Chinese and western medicine.
10.19540/j.cnki.cjcmm.20231007.501
- Author:
Yi-Fan HUI
1
;
Shuo-Qi ZHAO
1
;
Ting-Sheng LING
2
;
Liu LI
3
;
Ye ZHANG
2
;
Li-Mei GU
2
;
Xing LIAO
4
;
Hai-Bo CHENG
1
Author Information
1. the First Clinical Medical College of Nanjing University of Chinese Medicine/Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor Nanjing 210023, China Jiangsu Province Hospital of Chinese Medicine/Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China.
2. Jiangsu Province Hospital of Chinese Medicine/Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China.
3. the First Clinical Medical College of Nanjing University of Chinese Medicine/Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor Nanjing 210023, China.
4. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Beijing 100700, China.
- Publication Type:Journal Article
- Keywords:
colorectal adenoma;
guidelines;
integrated Chinese and western medicine;
prevention and treatment
- MeSH:
Humans;
Adenoma/prevention & control*;
Colorectal Neoplasms/prevention & control*;
Drugs, Chinese Herbal/therapeutic use*;
Evidence-Based Medicine;
Medicine, Chinese Traditional
- From:
China Journal of Chinese Materia Medica
2023;48(23):6269-6277
- CountryChina
- Language:Chinese
-
Abstract:
The Guidelines for prevention and treatment of colorectal adenoma with integrated Chinese and western medicine are put forward by Nanjing University of Chinese Medicine and approved by China Association of Chinese Medicine. According to the formulation processes and methods of relevant clinical practice guidelines, the experts in clinical medicine and methodology were organized to discuss the key problems to be addressed in the clinical prevention and treatment of colorectal adenoma(CRA) and provided answers following the evidence-based medicine method, so as to provide guidance for clinical decision-making. CRA is the major precancerous disease of colorectal cancer. Although the prevention and treatment with integrated Chinese and western medicine have been applied to the clinical practice of CRA, there is still a lack of high-quality guidelines. Four basic questions, 15 clinical questions, and 10 outcome indicators were determined by literature research and Delphi questionnaire. The relevant randomized controlled trial(RCT) was retrieved from CNKI, Wanfang, VIP, SinoMed, PubMed, EMbase, Cochrane Library, Web of Science, and 2 clinical trial registries, and finally several RCTs meeting the inclusion criteria were included. The data extracted from the RCT was imported into RevMan 5.3 for evidence synthesis, and the evidence was evaluated based on the Grading of Recommendations, Assessment, Development, and Evaluations(GRADE). The final recommendations were formed by the nominal group method based on the evidence summary table. The guidelines involve the diagnosis, screening, treatment with integrated Chinese and western medicine, prevention, and follow-up of colorectal adenoma, providing options for the clinical prevention and treatment of CRA.
